BioCryst Pharmaceuticals

Price & Volume

Stats

52W Range	$6-$11.31
Market Cap	$1.4B
Shares Short	36M

Financials

Revenue (12 Mos)	$599.8M
Revenue Growth (YoY)	36.1%
Gross Profit (12 Mos)	$410.4M
Diluted EPS	-$0.05

News

Yahoo Finance • 8 days ago

Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights

Yahoo Finance • 25 days ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 28 days ago

Here are the major earnings before the open Monday

Yahoo Finance • last month

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

About

CEO	Mr. Jon P. Stonehouse
CFO	Mr. Babar Ghias
Address	4505 Emperor Boulevard, Durham, NC, United States, 27703
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Full-Time Employees	580